Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Heavy Interest in OMHE :)
OMHE_OTCQB_Uplist_&_Share_Restructuring_Will_Be_Announced_Soon
Folks! OMHE will hit $1 soon. Don't Settle for Less
YES!! IT'S OBVIOUS :)
FDA approval is near. OMHE PPS will be $1 in few months!
Heavy Interest in OMHE shows the OTHERWISE :)
OMHE_Developed_Cannabinoid-Based_Medicine
Link To News
Ironically_OMHE,_A_Junk_Stock_Is_Favorit_&_Most_Talked_About_HERE_IS_WHY!!
Because_OMHE_is_Not_A_Junk_Stock_HERE_IS_WHY!!
What to expect now? major news announcements including but not limited to Share restructuring, OTCQB Uplist, MMJ based Therapeutic Medicine R&D update, FDA Clinical Trial Progress update, Major business acquisitions that will doubled the yearly revenue.
OMHE owns a Biotech R&D lab and scientists are working in it to develop cannabinoid-based drug therapies / medicines.
In few months, after all these announcements OMHE PPS will be close to $1
OMHE is not a junk but the most profitable OTC stock!!!
Finally, You got it - Yes, within 6 months!
OMHE_Applied_for_FDA_Registration_for_MJ_Based_Pain_Treatment_Medicine_Therapeutics
OMHE has 6 divisions:
Check Their Website
1) Specialty Pharmacy
2) Regenerative Medicine
3) Anti-Aging
4) Skincare Technologies
5) Cannabis Technologies
6) Global Wellness
OMHE has scientists, R&D Lab, plan and is ready to market/sell Marijuana based Pain treatment therapeutics and medicine. Also, OTCQB upgrade is on the way!
12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here
In few months, OMHE PPS will hit $1 mark
FDA Approval is expected in 2019
Link To 11/14/2017 OMHE CEO Letter
OMHE’s_ Cannabidiol_Products_To_Be_Exported_To_Europe._Capturing_Pain_Treatment_Market
Link To 11/14/2017 OMHE CEO Letter
OMHE_Developed_Marijuana_based_Medicine_Started_FDA_Registration_Process
12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here
Stock Markets are closed Today. Like this, I provide updated info on OMHE on this board!
OMHE fundamentals are solid. CBD Meds R&D results will be announced soon; FDA approval is on the way.....
OMHE IS THE LEADER OF THE MMJ BIOTECH INDUSTRY
* OMHE OTCQB Uplist is imminent
* OMHE had provided a detailed plan on 2/9/2017
* OMHE planned to acquire more businesses
* OMHE CEO has credentials and experience to envision and execute a successful business plan Read here then decide Also, his current track record proves that!
* OMHE owns and operates licensed highly lucrative pharmaceutical, medical and wellness business
* As Promised OMHE CEO released follow up to 2/9/2017 letter on 11/14/2017
* OMHE has developed Over The Counter cannabinoid biotherapeutics/medicine
* OMHE is marketing/selling Over The Counter cannabinoid biotherapeutics/medicine to Doctor’s offices, clinics, and hospitals to ensure appropriate usage
* OMHE to Collaborate/joint venture with one of the largest European cannabis companies.
* Licensed Medical marijuana cultivation about to start.
* OMHE applied to FDA for in-house developed prescription MJ Medicine approval
* OMHE PPS is heading to $ 1 PPS
OMHE's_R&D_is_in_$36Billion_Pain_Management_GlobalMarket
Link To News
OMHE has an advanced Biotech R&D lab and scientists have developed cannabinoid-based drug therapies / medicines. Clinical Trial Started
Click to Read News>>>OMHE had announced all this in 2017
OMHE’s_ Cannabidiol_Products_To_Be_Exported_To_Europe._Capturing_Pain_Treatment_Market
Link To 11/14/2017 OMHE CEO Letter
Ironically_OMHE,_A_Junk_Stock_Is_Favorit_&_Most_Talked_About_HERE_IS_WHY!!
Because_OMHE_is_Not_A_Junk_Stock_HERE_IS_WHY!!
What to expect now? major news announcements including but not limited to Share restructuring, OTCQB Uplist, MMJ based Therapeutic Medicine R&D update, FDA Clinical Trial Progress update, Major business acquisitions that will doubled the yearly revenue.
OMHE owns a Biotech R&D lab and scientists are working in it to develop cannabinoid-based drug therapies / medicines.
In few months, after all these announcements OMHE PPS will be close to $1
OMHE is not a junk but the most profitable OTC stock!!!
OMHE HAS SOLID REVENUE STREAM, DEVELOPED CBD_BASED MED, HEADED TO FDA FOR APPROVAL
WAY TO GO OMHE
Yes. Because OMHE's CBD Med is promising!!!
FDA_will_Approve_OMHE’s_CBD_based_Rx_Pain_Medicine_in_2019
OMHE gave conservative timeframe of three years as any public company would do but in reality this will happen sooner due to the following reasons:
(1) OMHE is reformulating its most successful (almost 4 decades old) proprietary formularies to include cannabidiol (CBD); so therapeutic is not new and has a proven record.
(2) OMHE is using FDA regulations-savvy, ‘fast-track’ pipeline strategy & will be in a position to partner for late-phase development. Minimum approval timeframe for phase-3 is 1 year.
(3) OMHE & others understand that due to current dreadful opioids epidemic, cannabidiol drug is the best alternative, therefore processing will be faster.
(4) OMHE said on Dec 5, 2017 that "plan already in motion".
12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here
So IMO, approval will be granted in 2019.
**********OMHE's Proven Track Record Of Delivery**********
OMHE_Developed_Marijuana_based_Medicine_Started_FDA_Registration_Process
12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here
OMHE is on the RiSE!!!!!!!!!!!!
OMHE’s_ Cannabidiol_Products_To_Be_Exported_To_Europe._Capturing_Pain_Treatment_Market
Link To 11/14/2017 OMHE CEO Letter
This is just due to not filing qtrly/yearly reports - not a big deal - has happened many times in the past. Just timely filings will fix it.
These_Six_Industries_Are_Separate_from_MALECON
These are part of OMHE's R&D conglomerate!!
JUST WATCH!!
OMHE is The Champion of 6 Pharmaceutical Industries
Check Their Website
1) Specialty Pharmacy
2) Regenerative Medicine
3) Anti-Aging
4) Skincare Technologies
5) Cannabis Technologies
6) Global Wellness
OMHE has scientists, R&D Lab, plan and is ready to market/sell Marijuana based Pain treatment therapeutics and medicine. Also, OTCQB upgrade is on the way!
OMHE_OTCQB_Uplist_&_Share_Restructuring_Will_Be_Announced_Soon
Other expected major events include OTCQB uplist, share restructuring etc.
OMHE_is_Working_on_Licensed_Medical_Marijuana_Cultivation
On 2/9/2017 OMHE CEO released 1st letter (Click Here to Read) to shareholders and most of the promises have been fulfilled as we can see Here and here in this 11/14/2017 CEO's 2nd Letter. One more the most important promise was licensed medical marijuana cultivation plan and I am expecting that will be implemented in next few months.
OMHE_is_following_GW_Pharmas_footsteps_in_obtaning_CBD_based_Pain_Meds_FDA_Approval
GW Pharma's CBD based Meds FDA Approved Clinical Trial News
OMHE has an advanced Biotech R&D lab and scientists have developed cannabinoid-based drug therapies / medicines. Clinical Trial Started
Click to Read News>>>OMHE had announced all this in 2017
OMHE_is_busy_with_CBD/MMJ_R&D_Trump_&_Schumer_support_CBD/MMJ
TRUMP & SCHUMER
Trump and Schumer's Support Of Marijuana Could Be Major Catalyst For These Companies<<<READ FULL STORY HERE
OMHE_with_CBD_Drug_@FDA_for_Approval_PRd>>Received_$7Mln_AntiAging_Cream_Order
OMHE disclosed in its NOV 2017 announcement about CBD Pain medicine development and in DEC 2017 updated on the initiation of FDA approval process. Later PUBLISHED THIS FASCINATING $7Million Rev Add news in an already $10Million Rev.
$7Million in Revenue Add News Link
OMHE<1c_Rev~$20Mil_FDAcbdMed_ShareRestruc_QBuplist_MMJcultivation_OvrTCntrCBD_NEXT
HERE is WHAT OMHE HAS ACCOMPLISHED SO FAR
(1) In Feb 2017 OMHE shared its vision and indicated its plan on working on therapeutic cannabis products and licensed medical marijuana cultivation.
CLICK HERE TO READ FEB 2017 OMHE VISION & FUTURE PLANS
(2) In My 2017 OMHE announced the opening of its Biotech R&D Lab.
CLICK HERE TO READ MAY 2017 LAB ANNOUNCEMENT
(3) In June 2017 Biotech scientists with FDA/regulatory approval joined OMHE.
CLICK HERE TO READ JUNE 2017 SCIENTISTS ANNOUNCEMENT
(4) In Nov 2017 OMHE updated about cannabinoid-based drug-development.
CLICK HERE TO READ NOV 2017 DRUG DEVELOPMENT UPDTE
(5) In Dec 2017 OMHE announced its plan already in motion to create a drug candidate compelling to Big Pharma, development of cannabidiol pain treatment therapeutic & medicine and filing of FDA registration by employing an FDA regulations-savvy, ‘fast-track’ pipeline strategy.
CLICK HERE TO READ DEC 2017 FDA REGISTRATION UPDATE
(6) In Dec 2017 OMHE announced launch of $7 million revenue generating Consumer Goods Division operating under subsidiary, Celebrity Brands Inc; plan of acquiring a number of consumer, revenue-generating brands, and by creating a platform for future acquisitions that scale the distribution of company’s existing brands; and first wholesale order is from Amerimark Direct for Celeb Cream – one of the Company’s innovative anti-aging products.
CLICK HERE TO READ DEC 2017 Consumer Goods Division ANNOUNCEMENT
(7) In Dec 2017 OMHE announced 3.7 Million Euro distribution agreement across Europe.
CLICK HERE TO READ DEC 2017 3.7 MILLION EURO DISTRIBUTION AGREEMENT
OMHE_NEXT_FY_REVENUE_WILL_BE_EVEN_MORE_THAN_$20Million
DEC-2017-PR-READ-HERE_OMHE_PROVIDED_A_SUCCESS_PLAN
Omni Health’s Consumer Goods Division will be operating via a subsidiary, Celebrity Brands Inc. Celebrity Brands will bring an entirely new reach to Omni Health’s operations with a new set of investment priorities and a sharpened set of portfolio choices to accelerate growth and performance. The company will also focus on strengthening its portfolio by acquiring a number of consumer, revenue-generating brands, and by creating a platform for future acquisitions that scale the distribution of company’s existing brands.
OMHE Stock Price is HEADING TO ONE DOLLAR
OMHE_has_already_announced_FDA_approval_comprehensive_plan_&_Several_contracts_details
I am expecting...now is the time for OMHE to give some positive updates. Let's see. Not sure if they are ready to update us or not!
FY2018 is ending on 4/30/2018. So at the start of FY2019, we should hear something BIG!
IMO